Related Experiment Video
Updated: Jun 3, 2026
07:25
Two-Photon Intravital Microscopy of Glioblastoma in a Murine Model
Published on: March 1, 2024
Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas
Anke Klose1, Yannic Waerzeggers, Parisa Monfared
1European Institute for Molecular Imaging, University of Münster, Germany.
Neoplasia (New York, N.Y.)
|March 11, 2011
Summary
Bone morphogenetic protein 7 (BMP-7) significantly inhibits glioma cell proliferation by arresting the cell cycle. This finding supports BMP-7 as a potential therapeutic agent for malignant gliomas.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Bone morphogenetic protein 7 (BMP-7) is a cytokine with context-dependent roles in tumorigenesis.
- Gliomas are primary brain tumors with significant therapeutic challenges.
Purpose of the Study:
- To investigate the antiproliferative effects of BMP-7 on glioma cells.
- To elucidate the molecular mechanisms underlying BMP-7's action in glioma.
Main Methods:
- In vitro studies using Gli36ΔEGFR-LITG glioma cells treated with BMP-7.
- Analysis of cell cycle progression, apoptosis, and key protein expression/phosphorylation (CDK2, p21, Rb).
- In vivo studies using intracranial xenografts in nude mice with optical imaging.
Main Results:
- BMP-7 treatment reduced glioma cell proliferation by up to 50% in vitro.
- BMP-7 induced G(1) cell cycle arrest without triggering apoptosis.
- Modulation of cyclin-dependent kinase 2, p21, and retinoblastoma protein expression/phosphorylation was observed.
- In vivo imaging confirmed the antiproliferative effect of BMP-7 in an intracranial glioma model.
Conclusions:
- BMP-7 exhibits a tumor-suppressive role in glioma-derived cells.
- Targeting the BMP/transforming growth factor β signaling pathway offers a potential therapeutic strategy for malignant gliomas.
- BMP-7 may be useful in imaging-guided molecular-targeted therapy for gliomas.
